Standard community protocols run tirzepatide alone for the first 8 weeks (2.5 5 mg/week) to confirm GI tolerance, then add cagrilintide at 0.25 mg/week starting Week 9
If you prioritize ease, comfort, and integrating a nightly routine, the nasal spray route is compelling
Patients taking certain medications (e.g., chloramphenicol may reduce the effectiveness of B12 therapy) or with risk factors for B12 deficiency (metformin use, proton pump inhibitors, nitrous oxide exposure, vegan diet) should discuss these with their healthcare provider
Supports enhanced muscle development, increased strength, and improved recovery particularly researched for muscle-wasting conditions and performance enhancement
DSIP is strictly intended for laboratory research